philanthropy.org | 990 Resource | FAQ Verify yourself Sign in
EK
Person · officer / director

Eric Koehrsen

Managing Director, Investments · Cystic Fibrosis Foundation

Managing Director, Investments at Cystic Fibrosis Foundation. Listed as an officer, director, or key employee across 1 organization on the Form 990 record.

Organizations
1
Roles reported
1
Reported compensation
$976K

Who this is

Profile

Everything on the left is verified from the IRS filings. The biography on the right is compiled from public web sources and grounded to that filed record.

✓ Verified from filings
Reported as Managing Director, Investments of Cystic Fibrosis Foundation, based in Bethesda, MD.
Received $976K in total reported compensation on the most recent Form 990 (Part VII).
Facts extracted directly from each organization's Form 990, Part VII.
Biography Web-sourced

Managing Director of Investments at the Cystic Fibrosis Foundation, managing a $5 billion investment portfolio supporting the organization's mission to find a cure for cystic fibrosis. Koehrsen brings diverse investment management experience from Cambridge Associates, Barclays Capital, Lincoln Financial Group, and Duke University.

Compiled from public web sources (3 cited), grounded to the filed record.

Track record

Career & tenure

Real tenure, career, and education — from public web sources, what you need to vet a founder or leader beyond the filing window.

Tenure here
Managing Director, Investments, Cystic Fibrosis Foundation (since 2018)
Education
  • 1998-2002) · Haverford College (Bachelor's in Economics and Spanish1998
  • 2009-2010) · Stanford University (Master's in Financial Mathematics2009

Verify independently

Find them online

Primary links to check this person directly — their own pages, not an aggregator.

Affiliations

Organizations

Cystic Fibrosis Foundation Managing Director, Investments · $355.8M revenue · Bethesda, MDTO CURE CYSTIC FIBROSIS (CF) AND TO PROVIDE ALL PEOPLE WITH CF THE (CONTINUED ON SCH O) OPPORTUNITY TO LEAD LONG, FULFILLING LIVES.pay $627K → $976KFiled FY2024, FY2023, FY2022, FY2021 · Source: Form 990, Part VII
$976Kreported comp

Network

Serves alongside

Other officers, directors & key employees at this person's organizations, by latest reported compensation.

J
Chief Investment Officer · FY2023
$2.7M
J
Chief Investment Officer · FY2022
$2.5M
J
Chief Investment Officer · FY2024
$1.9M
A
Managing Director, Investments · FY2024
$1.4M
E
Managing Director, Investments · FY2024
$1.2M
M
President & CEO · FY2024
$1.1M
E
Managing Director, Investments · FY2022
$1.0M
I
EVP & Chief Operating & Financial Officer · FY2024
$762K
J
SVP, Clinical Research · FY2024
$670K
G
Managing Director, Investments Operations · FY2024
$643K
A
VP, Clinical Development · FY2022
$574K
A
Chief Medical Officer Beg. 7/1/2024 · FY2024
$572K

Network

Recommendations

Written by other verified members of the network — visible once you're a verified person yourself.

Loading…

Explore

Similar organizations

Nonprofits working in the same field — explore who else operates in this space.

World Federation of Hemophilia USA$1.1B revenue · Albany, NY
United Cerebral Palsy of New York City INC$242.7M revenue · New York, NY
C
Center for Disability Services INC$125.8M revenue · Albany, NY
Upstate Cerebral Palsy INC$124.6M revenue · Utica, NY
March of Dimes INC$83.6M revenue · Arlington, VA

People like this

Similar leaders

Leaders at organizations in the same field, by reported compensation.

L
Physician · Boston Pediatric Neurosurgical Foundation INC
$4.8M
N
CEO · American Heart Association INC
$4.5M
R
Director/Chair/Pres/CEO · Stowers Resource Management INC
$3.0M
J
Chief Investment Officer · Cystic Fibrosis Foundation
$2.7M
J
Chief Investment Officer · Cystic Fibrosis Foundation
$2.5M
B
Medical Oncology · Central Arkansas Radiation Therapy
$2.1M
Public data from IRS Form 990 e-file & the Business Master File. Individuals appear here because they were named as an officer, director, or key employee on a nonprofit's Form 990; people are grouped by name plus corroborating evidence (Schedule R, shared address, shared board members). · philanthropy.org